{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,11]],"date-time":"2026-10-11T20:47:36Z","timestamp":1791751656237,"version":"4.3.4"},"reference-count":22,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bone"],"published-print":{"date-parts":[[2027,1]]},"DOI":"10.1016\/j.bone.2026.118103","type":"journal-article","created":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T23:34:14Z","timestamp":1790206454000},"page":"118103","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Revisiting drug guidelines for paediatric skeletal disorders: Implications for dental management"],"prefix":"10.1016","volume":"214","author":[{"given":"Selwin G.","family":"Samuel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Craig F.","family":"Munns","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sobia","family":"Zafar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.bone.2026.118103_bb0005","doi-asserted-by":"crossref","first-page":"33","DOI":"10.55275\/JPOSNA-2019-33","article-title":"The role of bisphosphonates in pediatric orthopaedics: what do we know after 50 years?","volume":"1","author":"Laine","year":"2019","journal-title":"J. Pediatr. Orthop. Soc. N. Am."},{"issue":"6","key":"10.1016\/j.bone.2026.118103_bb0010","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1007\/s11914-017-0409-5","article-title":"Dental manifestations of pediatric bone disorders","volume":"15","author":"Yepes","year":"2017","journal-title":"Curr. Osteoporos. Rep."},{"issue":"3","key":"10.1016\/j.bone.2026.118103_bb0015","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.joms.2006.10.061","article-title":"Nature and frequency of bisphosphonate-associated osteonecrosis of the jaws in Australia","volume":"65","author":"Mavrokokki","year":"2007","journal-title":"J. Oral Maxillofac. Surg."},{"issue":"8","key":"10.1016\/j.bone.2026.118103_bb0020","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1056\/NEJMoa0809493","article-title":"Denosumab for prevention of fractures in postmenopausal women with osteoporosis","volume":"361","author":"Cummings Steven","year":"2009","journal-title":"N. Engl. J. Med."},{"issue":"10","key":"10.1016\/j.bone.2026.118103_bb0025","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.1016\/j.joms.2014.04.031","article-title":"American association of oral and maxillofacial surgeons position paper on medication-related osteonecrosis of the jaw\u20142014 update","volume":"72","author":"Ruggiero","year":"2014","journal-title":"J. Oral Maxillofac. Surg."},{"issue":"6","key":"10.1016\/j.bone.2026.118103_bb0030","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1111\/j.1365-2265.2008.03189.x","article-title":"Bisphosphonate-associated osteonecrosis of the jaw: does it occur in children?","volume":"68","author":"Brown","year":"2008","journal-title":"Clin. Endocrinol."},{"issue":"5","key":"10.1016\/j.bone.2026.118103_bb0035","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/j.jpeds.2008.05.003","article-title":"Tooth extraction socket healing in pediatric patients treated with intravenous pamidronate","volume":"153","author":"Chahine","year":"2008","journal-title":"J. Pediatr."},{"issue":"10","key":"10.1016\/j.bone.2026.118103_bb0040","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1016\/j.joms.2024.06.162","article-title":"The risk of medication-related osteonecrosis of the jaw in children: guidance for antiresorptive use in pediatric patients","volume":"82","author":"Lasky","year":"2024","journal-title":"J. Oral Maxillofac. Surg."},{"issue":"4","key":"10.1016\/j.bone.2026.118103_bb0045","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/j.joms.2025.11.007","article-title":"Medication-related osteonecrosis of the jaw in the pediatric population: a systematic review of current literature","volume":"84","author":"Mohseni","year":"2026","journal-title":"J. Oral Maxillofac. Surg."},{"issue":"3","key":"10.1016\/j.bone.2026.118103_bb0050","doi-asserted-by":"crossref","first-page":"470","DOI":"10.21037\/tp-22-276","article-title":"Denosumab in pediatric bone disorders and the role of RANKL blockade: a narrative review","volume":"12","author":"Wang","year":"2023","journal-title":"Transl. Pediatr."},{"issue":"6","key":"10.1016\/j.bone.2026.118103_bb0055","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1038\/s41415-024-7139-8","article-title":"Medication-related osteonecrosis of the jaw in a paediatric patient taking denosumab: a case report","volume":"236","author":"Innes-Taylor","year":"2024","journal-title":"Br. Dent. J."},{"issue":"1","key":"10.1016\/j.bone.2026.118103_bb0060","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1111\/adj.12140","article-title":"The use of bisphosphonates in children: review of the literature and guidelines for dental management","volume":"59","author":"Bhatt","year":"2014","journal-title":"Aust. Dent. J."},{"key":"10.1016\/j.bone.2026.118103_bb0065","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.jdsr.2022.03.001","article-title":"Management of bisphosphonate preparation-treated children in the field of pediatric dentistry","volume":"58","author":"Mitsuhata","year":"2022","journal-title":"Jpn. Dent. Sci. Rev."},{"issue":"4","key":"10.1016\/j.bone.2026.118103_bb0070","first-page":"285","article-title":"Paediatric dentists treating children on bisphosphonates: a cross-sectional questionnaire-based study","volume":"41","author":"Lau","year":"2019","journal-title":"Pediatr. Dent."},{"issue":"5","key":"10.1016\/j.bone.2026.118103_bb0075","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1016\/j.jormas.2020.03.003","article-title":"Bisphosphonate-related osteonecrosis of the jaws and dental surgery procedures in children and young people with osteogenesis imperfecta: a systematic review","volume":"121","author":"Contaldo","year":"2020","journal-title":"J. Stomatol. Oral Maxillofac. Surg."},{"issue":"1_suppl","key":"10.1016\/j.bone.2026.118103_bb0080","first-page":"362S","article-title":"Extensive tongue laceration in an edentulous infant: is it child abuse?","volume":"104","author":"Bernstein","year":"2023","journal-title":"Ear Nose Throat J."},{"issue":"6","key":"10.1016\/j.bone.2026.118103_bb0085","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1016\/j.jemermed.2013.05.004","article-title":"Pediatric tongue laceration repair using 2-octyl cyanoacrylate (Dermabond\u00ae)","volume":"45","author":"Kazzi","year":"2013","journal-title":"J. Emerg. Med."},{"issue":"5","key":"10.1016\/j.bone.2026.118103_bb0090","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1016\/j.joms.2022.02.008","article-title":"American Association of Oral and Maxillofacial Surgeons\u2019 position paper on medication-related osteonecrosis of the jaws-2022 update","volume":"80","author":"Ruggiero","year":"2022","journal-title":"J. Oral Maxillofac. Surg."},{"key":"10.1016\/j.bone.2026.118103_bb0095","doi-asserted-by":"crossref","DOI":"10.1016\/j.bone.2024.117069","article-title":"Influence of zoledronic acid and pamidronate on tooth eruption in children with osteogenesis imperfecta","volume":"182","author":"Del Rio Cantero","year":"2024","journal-title":"Bone"},{"issue":"1","key":"10.1016\/j.bone.2026.118103_bb0100","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1186\/s12903-024-04557-3","article-title":"Root resorption of primary molars and dental development of premolars in children with Osteogenesis Imperfecta medicated with bisphosphonates, grouped according to age and gender","volume":"24","author":"Garcete Delvalle","year":"2024","journal-title":"BMC Oral Health"},{"issue":"1","key":"10.1016\/j.bone.2026.118103_bb0105","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/s00223-025-01345-1","article-title":"Eruptive process in children with osteogenesis imperfecta","volume":"116","author":"Garcete Delvalle","year":"2025","journal-title":"Calcif. Tissue Int."},{"issue":"3","key":"10.1016\/j.bone.2026.118103_bb0110","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1111\/jpc.13768","article-title":"Consensus guidelines on the use of bisphosphonate therapy in children and adolescents","volume":"54","author":"Simm","year":"2018","journal-title":"J. Paediatr. Child Health"}],"container-title":["Bone"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S8756328226003297?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S8756328226003297?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,11]],"date-time":"2026-10-11T20:42:44Z","timestamp":1791751364000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S8756328226003297"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2027,1]]},"references-count":22,"alternative-id":["S8756328226003297"],"URL":"https:\/\/doi.org\/10.1016\/j.bone.2026.118103","relation":{},"ISSN":["8756-3282"],"issn-type":[{"value":"8756-3282","type":"print"}],"subject":[],"published":{"date-parts":[[2027,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Revisiting drug guidelines for paediatric skeletal disorders: Implications for dental management","name":"articletitle","label":"Article Title"},{"value":"Bone","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bone.2026.118103","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"118103"}}